Category
66 releases
The U.S. Food and Drug Administration today granted accelerated approval for Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd)…
SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that uses acoustic pressure waves, similar to those used to break up…
Company to hold a conference call at 8AM ET on November 5, 2026 to review results and provide a corporate update SHELTON, Conn., Oct. 30, 2026 —…
INOVIO delivers a new nonsurgical treatment option with a broad indication for adults living with RRP, a rare and debilitating disease that often…
Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), an oncology-focused biopharmaceutical company and majority-owned…
The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2026 of $1.73 per share on outstanding…
KEYNOTE-C93/GOG-3064/ENGOT-en15 results presented in the ESMO 2026 Presidential Symposium and published simultaneously in The Lancet MIAMI BEACH,…
A study coauthored by Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD is among the…
Made Scientific to integrate multiple UniFuge® single-use centrifugation systems across its Princeton, NJ, and East Norriton, PA, facilities to…
A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows. The drug, called…
Research conducted in partnership with University College London examines personalised dosing, clinical monitoring and metabolic health outcomes in…
All five patients complete six-month follow-up without predefined prosthesis-related safety events BERLIN, Oct. 26, 2026 — GrOwnValve GmbH, a…
Northwest Biotherapeutics (OTCQB: NWBO) NWBio a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers,…
The JAK inhibitors market is expected to witness steady growth, driven by the increasing prevalence of autoimmune and inflammatory diseases, growing…
Automated system enables rapid, reproducible formulation screening with minimal sample consumption Completes the NanoCalibur® Series (Mini, Lab, Pro,…
Sword Bio and Alturas Analytics today announced a strategic collaboration designed to provide biotechnology and pharmaceutical companies with…
As drug pipelines grow faster than site capacity, Florence moves from storing trial work to doing it, with research teams in charge of the decisions…
Median overall survival of 12 months with RBS2418 monotherapy in subjects with heavily pretreated tumors that express ENPP1 and cGAS proteins…
Celebrating the clinically proven treatment that has become the leader*1 in professional microneedling NASHVILLE, Tenn., Oct. 26, 2026 — Revance, a…
Presented at the NORD Breakthrough Summit, the findings show EDS patients wait a median of nearly eight years for a diagnosis, a delay that…
